Rami Elghandour, Arcellx CEO

Biotech bear mar­ket be damned, CAR-T play­er Ar­cel­lx rais­es $123M IPO

The cur­rent biotech bear mar­ket doesn’t mean it’s im­pos­si­ble for a new biotech to have a suc­cess­ful IPO, mere­ly hard­er.

On Fri­day, CAR-T com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA